clenbuterol has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y | 1 |
| Liu, S | 1 |
| Yin, X | 1 |
| Wang, S | 1 |
| Tian, Y | 1 |
| Shu, R | 1 |
| Jia, C | 1 |
| Chen, Y | 1 |
| Sun, J | 1 |
| Zhang, D | 1 |
| Zhu, M | 1 |
| Wang, J | 1 |
1 other study available for clenbuterol and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Nature-inspired nanozymes as signal markers for in-situ signal amplification strategy: A portable dual-colorimetric immunochromatographic analysis based on smartphone.
Topics: Biomarkers; Biosensing Techniques; Clenbuterol; Colorimetry; Coloring Agents; Gallic Acid; Humans; I | 2022 |